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Gabapentin (1-(aminomethyl)cycloheaxaneacetic acid; 
Gpn) is a widely used anti-ep leptic drug. The target 
site of action of Gpn remains controversial. Gpn can 
exist in two isomeric chair forms. The crystal structures 
of Gpn 1 and eight derivatives, Gpn hydrochloride 2, 
Gpn lactam 3, Boc-Gpn-OH 4, Ac-Gpn-OH 5, Piv-
Gpn-OH 6, Tosyl-Gpn-OH 7, Boc-Gpn-OSu 8 and 
Boc-Gpn-NHMe 9, are described. The aminomethyl 
group occupies an axial positi n in 1, 3, 6 and 7, while 
it lies in an equatorial orientation in 2, 4, 5 and 8. The 
structure of Boc-Gpn-NHMe 9 reveals that the crystals 
contain both chair forms of the derivative in the ratio 
0.7 : 0.3, favouring the aminomethyl group in an axial 
position. In all cases, the torsional angles about the 
Ca–Cb (q1) and C
b–Cg (q2) bonds of the g-amino acid 
residue are characteristic of a gauche, gauche (g, g) 
conformation. In solution, NMR studies establish 
rapid conformational exchange, as anticipated, at room 
temperature. Low temperature NMR studies permit 
conformational freezing and determination of the free-
energy differ nce between the two 1,1-disubstiuted 
cyclohexane conformers. The largest free-energy diffe-
rence is observed in the free amino acid (0.38kcal mol–1), 
with the most stable conformer having the amino-
methyl group in the equatorial position. The free-energy 
difference between the two forms is significantly reduced 
in the protected derivatives, with almost equal pop-
lations observed in solution for the fully protected 
neutral derivatives, Boc-Gpn-NHMe and Gpn lactam. 
THE role of g-aminobutyric acid (GABA) as an inhibitory 
neurotransmitter has stimulated an enormous amount of
activity on the synthesis of GABA analogues as potential 
central nervous system agents1. Gabapentin (1-(amino-
methyl) cyclohexaneacetic acid; Gpn) has been introduced as 
an anti-epileptic drug which is orally active2. Mor  recently, 
Gpn (NeurontinÒ) has been advanced for the treatment of 
neuropathic pain3. The mechanism of action of Gpn remains 
a subject of considerable discussion4. g-Aminobutyric acid 
type-B receptors have been suggested as sites for Gpn 
action5. However, subsequent work led to the conclusion 
that Gpn has no agonist-like activity at GABAB receptor 
heterodimers6,7. A high affinity Gpn binding site has been 
demonstrated on the a2d subunit of a calcium channel
8. 
Both Gpn and its analogue pregabalin, (S-(+)-3-isobutyl 
GABA), have been shown to inhibit neuronal Ca2+ influx 
in the human motor cortex, suggesting that the site of 
action of the drug may be a voltage-dependent Ca2+ 
channel9,10. Gpn has also been shown to have modest 
inhibitory activity on branched chain amino acid trans-
ferases (BCAT), with distinctly different effects on vari-
ous isozymes11. The branched chain amino acid metabolic 
pathways have been implicated in several neurological 
disorders12. 
 Despite its structural simplicity, Gpn can exist in two 
distinct conformations corresponding to the two inter-
convertible chair forms of the cyclohexane ring. Figure 1 
schematically illustrates the consequences of the confor-
ational interconversion for interaction at a potential 
rec ptor site. In principle, three major elements of inter-
action can be considered; two involving electrostatic anchor-
ing of the charged alkylamino and carboxylate groups, 
while the third would be mediated by apolar (hydro-
phobic) contacts between the hydrocarbon ring and a  
potential nonpolar group on the receptor. In this simplistic, 
three-point attachment model, originally formulated by 
Ogston13, any chiral receptor site would be readily able to 
distinguish between two possible chair conformations, 
suggesting that a specific biological activity may be medi-
ated by a single conformation. The conformational require-
ments for Gpn biological activity have been probed using 
3-methyl substituted derivatives, specifically the cis and 
trans isomers of (3R)-(1-aminomethyl-3-methylcyclohexyl)-
acetic acid14,15. 
 Despite its widespread clinical use, the only publicly 
available structures of Gpn are those reported in single 
crystals by Ibers, who described both the free amino acid 
and its monohydrate16. We have undertaken a systematic 
study of the structures of Gpn and its derivatives in order 
to probe the factors which determine the conformational 
distributions in this class of 1,1-disubstituted cyclo-
hexanes14. We discuss in this article, crystal structures of 
the free amino acid Gpn 1 a d eight derivatives, namely 
Gpn hydrochloride 2, Gpn lactam 3, Boc-Gpn-OH (t-
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butyloxycarbonyl-gabapentin-OH) 4, Ac-Gpn-OH (acetyl-
gabapentin-OH) 5, Piv-Gpn-OH (pivaloyl-gabapentin-OH) 
6, Tosyl-Gpn-OH 7, Boc-Gpn-OSu (Boc-gabapentin-N-
hydroxysuccinimide ester) 8 and Boc-Gpn-NHMe 9. 
NMR evidence for the conformational interconversion 
and estimated free-en rgy differences between the two 
forms in Gpn and its derivatives are also reported. The 
stereochemistry of Gpn and its derivatives is also specially 
relevant in view of the growing interest in the use of g-amino 
acid residues in the design of peptides of structural and 
biological importance17–20. 
Experimental procedure 
Synthesis 
Gpn 1, Gpn hydrochloride 2 and Gpn lactam 3 were the pro-
ducts of Hikal Ltd, Bangalore, India. The N-protected deri-
vatives were prepared by standard procedures and purifi d. 
Boc-Gpn-OH 4 
This was obtained as a white crystalline solid by treat-
ment of the free amino acid with di-tert-butyldicarbonate 
[(Boc)2O] using a reported procedure
21. Yield 90%; m.p. 
127–128°C. 
Ac-Gpn-OH 5/Piv-Gpn-OH 6 
Gpn-OH (0.65 g, 5 mmol) was dissolved in 2N NaOH 
(10 ml) and cooled in an ice-bath. Ac- hloride/Piv-chloride 
(6 mmol) was added over a period of 30 min maintaining 
pH 8–9. After the addition was complete, the reaction mix-
ture was slowly allowed to come to room temperature 
and stirring was continued for another 2 h. The reaction 
mixture was diluted with water (10 ml) and washed with 
ether, the aqueous layer was cooled and acidified with 6N 
HCl and then extracted with ethyl acetate. The organic 
layer was dried over Na2SO4 and evaporated. Recrystal-
lization using ethyl acetate/petroleum ether gave Ac-Gpn-
OH/Piv-Gpn-OH as white crystalline solids. Ac-Gpn-OH: 
Yield 850 mg (80%); m.p. 125–126°C. Piv-Gpn-OH: 
Yield 1.10g (87%); m.p. 89–90°C. 
Tosyl-Gpn-OH 7 
This was prepared by treatment of the free amino acid 
with tosyl chloride using a reported procedure21, yielding 
a white crystalline solid. Yield 82%; m.p. 115–116°C. 
Boc-Gpn-OSu 8 
To a stirred, ice- old solution of Boc-Gpn-OH (1.35 g, 
5 mmol) and N-hydroxysuccinimide (0.69 g, 6 mmol) in 
dry ethyl acetate (20 ml), dicyclohexyl carbodiimide (1.03 g, 
5 mmol) was added and the reaction mixture was allowed 
to attain room temperature. After 12 h, dicyclohexyl urea 
was filtered-off and the filtrate was washed with 1N HCl, 
1M Na2CO3 and brine solution. The organic layer was 
dried over Na2SO4 and evaporated. Recrystallization using 
ethanol gave Boc-Gpn-OSu as a white crystalline solid. 
Yield 1.65 g, (89%); m.p. 171–172°C. 
Boc-Gpn-NHMe 9 
Boc-Gpn-OH (0.54 g, 2 mmol) was dissolved in dry THF 
(5 ml) and cooled to 0°C in an ice-salt bath. TEA (0.3 ml, 
2 mmol) was added followed by ethyl chloroformate 
(0.26 ml, 2 mmol). After 10 min, 10 ml of dry THF satu-
rated with methylamine gas was added. After 2 h, the 
reaction mixture was filtered and the filtrate evaporated 
under vacuum. The residue was dissolved in ethyl acetate 
and washed with 1N HCl, 1N Na2CO3 and water. Evapo-
ration of ethyl acetate gave Boc-Gpn-NHMe as a white 
solid, which was purified by medium pressure liquid 
chromatography over a reverse-pha  C18 column (40–
60 mm). Yield 480 mg (84%); m.p. 87– 8°C. 
X-ray diffraction 
Single crystals suitable for X-ray diffraction were obtained 
by slow evaporation of concentrated solutions in aque-
ous/organic solvents. Table 1 summarizes the crystal and 
diffraction data for the compounds 1 to 9. X-ray data 
were collected at room temperature on a Bruker AXS 
SMART APEX CCD diffractometer using Mo Ka radia-
tion (l = 0.71073 Å). w-Scan type was use. In the cas  of 
Boc-Gpn-NHMe, diffraction data were collected at  
– 73°C to address the issue of disorder. All the structures 
were obtained by direct methods using SHELXS-97 (ref. 
22). Refinement was carried out against F2 w th full matrix 
 
 
 
 
Figure 1. (Top) Gabapentin, 1-(aminomethyl)cycloheaxaneacetic 
acid. (Bottom) Superposition of the two possible chair forms of the 
1,1-disubstituted cyclohexane. 
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Table 1. Crystal and diffraction parameters 
      
      
 Gabapentin 1 Gabapentin HCl 2 Gabapentin lactam 3 Boc-Gpn-OH 4 Ac-Gpn-OH 5 
            
Empirical formula C9 H17 N1 O2 C9 H17 N1 O2 
HCl 1/2 H2O 
C9 H15 N1 O1 C14 H25 N1 O4 C11 H19 N1 O3 
Crystal habit Clear, rod Clear, rectangular Clear, thin plates Clear, rectangular Clear, rod 
Crystal size (mm) 0.6 × 0.2 × 0.08 0.6 × 0.36 × 0.35 0.52 × 0.1 × 0.04 0.4 × 0.2 × 0.1 0.46 × 0.18 × 0.18 
Crystallizing solvent Water Water Hexane/ethyl acetate Ethyl acetate Methanol 
Space group P 21 /c C 2/c C 2/c P 21 /c P 21 /c 
Cell parameters      
 a (Å) 5.9034(16) 27.831(6) 22.243(7) 12.061(3) 7.877(4) 
 b (Å) 6.9193(19) 6.537(15) 6.187(19) 11.0628(3) 7.440(3) 
 c (Å) 22.476(6) 13.369(3) 13.352(4) 12.026(3) 19.875(9) 
b (deg) 90.062(4) 111.911(3) 108.513(8) 107.907(4) 93.087(7) 
Volume (Å3) 918.1(4) 2256.6(9) 1742.4(9) 1526.9(7) 1163.2(9) 
Z 4 8 8 4 4 
Molecules/asymmetric unit 1 1 1 1 1 
Cocrystallized solvent None H2O None None None 
Molecular weight 171.24 216.70 153.22 271.35 213.27 
Density (g/cm3)(cal) 1.239 1.276 1.168 1.18 1.218 
F (000) 376 936 672 592 464 
Radiation Mo Ka Mo Ka Mo Ka Mo Ka Mo Ka 
Temperature (°C) 21 21 21 21 21 
2q max. (°) 53.72 53.84 55.22 55.5 53.1 
Measured reflections 9210 8142 8774 12172 8045 
Rint 0.1566 0.0279 0.0366 0.0266 0.0179 
Independent reflections 1934 2265 1888 3316 2264 
Observed reflections  
 [êF ê > 4 s  (F )] 
1778 2052 1501 2318 1930 
Final R(%)/wR2(%) 5.35/14.5 3.26/9.03 5.97/15.52 5.70/14.14 4.56/12.90 
Goodness-of-fit (S) 1.075 1.043 1.070 1.002 1.045 
Dr max (e Å–3) / Dr min (e Å–3) 0.74/– 0.21 0.30/– 0.23 0.25/– 0.14 0.28/– 0.13 0.25/– 0.16 
No. of restraints/parameters 0/177 0/200 0/160 0/272 0/212 
Data-to-parameter ratio 10 : 1 10.3 : 1 9.4 : 1 8.5 : 1 9.1 : 1 
 
            
 Piv-Gpn-OH 6 Tosyl-Gpn-OH 7 Boc-Gpn-OSu 8 Boc-Gpn-NHMe 9a Boc-Gpn-NHMea 9b 
            
Empirical formula C14 H25 N1 O3 C16 H23 N1 O4 S1 C18 H28 N2 O6 C15 H28 N2 O3 C15 H28 N2 O3 
Crystal habit Clear, thin plates Clear, rod Clear, cubic Clear, thin plates Clear, rod 
Crystal size (mm) 0.47 × 0.11 × 0.002 0.5 × 0.3 × 0.03 0.35 × 0.25 × 0.25 0.5 × 0.3 × 0.02 0.4 × 0.1 × 0.08 
Crystallizing solvent Methanol/water Ethyl acetate/  
petroleum ether 
Ethyl acetate Methanol Methanol 
Space group P 21 /c P na21 P 21 /c Pbcn Pbcn 
Cell parameters      
 a (Å) 18.985(8) 24.676(7) 15.068(14) 30.040(5) 29.781(13) 
 b (Å) 9.144(4) 11.681(3) 12.396(12) 11.274(2) 11.203(5) 
 c (Å) 8.632(4) 24.015(6) 11.373(11) 9.821(17) 9.792(4) 
b (deg) 96.750(7) 90.0 112.170(2) 90 90 
Volume (Å3) 1488.1(10) 6922.0(3) 1967.0(3) 3326.1(10) 3267.0(2) 
Z 4 16 4 8 8 
Molecules/asymmetric unit 1 4 1 1 1 
Cocrystallized solvent None None None None None 
Molecular weight 255.35 325.41 368.42 284.39 284.39 
Density (g/cm3)(cal) 1.140 1.249 1.244 1.136 1.156 
F (000) 560 2784 792 1248 1284 
Radiation Mo Ka Mo Ka Mo Ka Mo Ka Mo Ka 
Temperature (°C) 21 21 21 21 – 73 
2q max. (°) 53.8 53.68 52.9 54.08 52.86 
Measured reflections 10698 69275 8818 23959 21811 
R int 0.027 0.0250 0.1432 0.0371 0.088 
Independent reflections 2931 13909 3515 3383 3140 
Observed reflections  
[êF ê > 4 s  (F )] 
2048 10043 2404 2487 1975 
Final R(%)/wR2(%) 6.15/14.18 5.04/13.33 7.32/17.81 8.9/19.30 6.8/18.83 
Goodness-of-fit (S) 1.137 1.017 1.135 1.180 1.06 
Dr max (e Å–3)/Dr min (e Å–3) 0.25/– 0.14 0.25/– 0.19 0.27/– 0.27 0.41/– 0.34 0.55/– 0.54 
No. of restraints/parameters 0/263 3/819 0/347 1/281 6/283 
Data-to-parameter ratio 7.8 : 1 12.3 : 1 6.9 : 1 8.8 : 1 7 : 1 
            
aData for the low-temperature structure. 
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least squares methods using SHELXL-97 (ref. 23). The 
hydrogen atoms were located from difference Fourier 
maps, except in the case of the disordered cyclohexane 
ring in Boc-Gpn-NHMe and Tosyl-Gpn-OH, where the 
hydrogen atoms were geometrically fixed. The crystallo-
graphic coordinates and temperature factors for the struc-
tures are deposited at the Cambridge Crystallographic 
Data Centre with deposition numbers 1, CCDC 217734; 
2, CCDC 217735; 3, CCDC 217736; 4, CCDC 217737; 5,
CCDC 217738; 6, CCDC 217739; 7, CCDC 217740;  
8, CCDC 217741; 9a, CCDC 217742 and 9b, CCDC 
217743. These data can be obtained free of charge via 
www.ccdc.cam.ac.uk/conts/retrieving.html (or from the 
Cambridge Crystallographic Data Centre, 12 Union Road, 
Cambridge CB21EZ, UK; Fax: (+44) 1223-336-033; e-mail: 
deposit@ccdc.cam.ac.uk). 
NMR spectroscopy 
The 1H NMR spectra were recorded on a BRUKER AMX 
400 MHz spectrometer. Spectra were recorded in methanol 
(CD3OD) solution and are referenced with respect to inter-
nal tetramethylsilane. Equilibration times of about 15–
20 min were used in the low-temperature spectra. 
Results and discussion 
Figures 2 and 3 show views of the molecular conformation 
of Gpn 1, Gpn hydrochloride 2, Gpn lactam 3, Boc-Gpn-
OH 4, Ac-Gpn-OH 5, Piv-Gpn-OH 6, Tosyl-Gpn-OH 7, 
Boc-Gpn-OSu 8, Boc-Gpn-NHMe 9a, and Boc-Gpn-NHMe 
(at – 73°C) 9b. In the case of 7, there are four independent 
molecules in the asymmetric unit. Two positions with an 
occupancy of 0.7 : 0.3 are observed for the terminal carbo-
xylic acid groups in molecules 7A and 7B, corresponding 
to rotation about the Ca–CO (y) bond (Table 2). Table 2 
lists the orientation of the aminomethyl and carboxymethyl 
substituents on the cyclohexane ring. In Boc-Gpn-NHMe 
both conformations of the cyclohexane ring are observed, 
with partial occupancy. The torsion angles f, q1, q2 and 
y, which are important in considering the use of Gpn in 
peptide design, are also listed in Table 2. Intramolecular 
hydrogen bonds are observed in four structures, the hydro-
chloride 2 and the three N-protected gabapentin derivatives 
4, 5 and 6. In Gpn hydrochloride, a seven-membered N–
H×××O hydrogen bond between the protonated amino 
group and the carbonyl oxygen of the protonated carboxylic 
acid group is observed. The conformations of the three 
N-protected derivatives 4, 5 and 6 are of interest in consi-
dering the nature of local folding patterns when the Gpn 
residue is introduced into peptide chains. In Boc-Gp -OH 
4 and Piv-Gpn-OH 6, a seven-membered N–H×××O hydro-
gen bond between the Gpn N-H group and the carbonyl 
group of the t rminal carboxylic acid group is observed. 
In the cases of 2, 4 and 6, the carboxylic acid group 
adopts the expected syn conformation. In Ac-Gpn-OH 5, 
a nine-membered intramolecular hydrogen bond is formed 
between the acetyl C=O group and the OH moi ty of the 
terminal carboxylic acid. Interestingly, the carboxylic 
acid adopts the infrequently observed anti conformation. 
A similar local conformation for a C-terminus Gpn residue 
has been observed in the N-protected dipeptides Piv-Pro-
Gpn-OH and Boc-Aib-Gpn-OH, with the terminal COOH 
group adopting an anticonformation20. 
Cyclohexane conformation 
In all the nine structures, the cyclohexane ring adopts an 
almost perfect chair conformation. The average endocyclic 
torsion angles and their estimated standard deviations (in 
parentheses) in Gpn and its derivatives are: 1 53.7° (3.18); 
2 53.9° (1.53); 3 54.7° (2.13); 4 54.3° (1.83); 5 53.9° 
(1.97); 6 53.7° (1.59); 7A 53.3° (2.18); 7B 53.5° (2.44); 7C 
53.5° (3.59); 7D 53.2° (4.37); 8 53.8° (1.36); 9b (amino-
methyl axial) 58.8° (4.22); 9b (aminomethyl equatorial) 
41.3° (6.41). The mean value obtained by averaging over 
all the Gpn derivative structu es is 53.3° (1.86). Classical 
studies on cyclohexane by electron diffraction yield a value 
of 55.9° (ref. 24), while X-ray diffraction studies on cyclo-
hexane derivatives resulted in values of 55.4° (axial substi-
tution)25 and 55.0° (equatorial substitution)25. 
 The structure determined for the free amino acid Gpn 
1, is practically identical to that reported by Ibers16, who 
also described the structure of its hydrate. Gpn poly-
morphs have been discussed in the patent literature and 
characterized by powder X-ray diffraction data26. However, 
no single-crystal X-ray diffraction structure of a poly-
morph is reported. During the course of our study, we 
made several attempts to obtain single crystals of poly-
morphic forms using a variety of crystallization condi i s, 
but were unsuccessful; always recovering the same form  
as 1. This is unsurprising, as the literature has several 
well-studied examples of recalcitrant polymorphs27. 
Orientation of substituents 
The conformation in crystals of Gpn 1 has the aminomethyl 
gro p inan axial position. The structure of the hydro-
chloride salt 2 which crystallizes as a hemihydrate, yields 
the alternative conformation, which has the carboxy-
methyl group axial. Gpn lactam 3, is a derivative which has 
been reported to be neuroprotective in retinal ischemia28. 
The crystal structure of the lactam reveals a conform tion 
in which the aminomethyl group is axial. The torsion angle 
about the amide bond in the lactam, – 0.3°, is indicative of a 
erfectly planar cis amide conformation. Boc-Gpn-OH 4 
and Ac-Gpn-OH 5 crystallize in the conformation with 
the carboxymethyl group in the axial orientation. Piv-Gpn-
OH 6 has an axial aminomethyl group in the crystal struc-
ture. All the four independent molecules observed in the 
crystal structure of Tosyl-Gpn-OH 7, adopt a conformation 
with the aminomethyl group in the axial position. The  
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Figure 2. Molecular conformation in crystals observed for Gpn 1, Gpn hydrochloride 2, Gpn lactam 3, Boc-Gpn-OH 4, Ac-Gpn-OH 5 and Piv-
Gpn-OH 6. Dotted lines indicate hydrogen bonds. 
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Figure 3. Molecular conformation in crystals observed for Tosyl-Gpn-OH 7, Boc-Gpn-OSu 8 and Boc-Gpn-NHMe 9. Note that for 9, structure 
determination carried out at room temperature and at – 73°C yielded identical structures. Both possible chair forms are present in the crystal with 
an occupancy ratio of 0.7 : .3 (axial: equatorial amino ethyl group). 
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fully-protected derivative, Boc-Gpn-OSu 8 crystallizes 
with carboxymethyl group in the axial position. The other 
fully-protected derivative Boc-Gpn-NHMe 9 reveals an 
interesting disorder in the crystals with both forms, amino-
methyl axial and carboxymethyl axial being present in 
the crystals, with an occupancy of 0.7 : 0.3, respectively. 
This form presents a frozen view of the distribution in 
solution with the two conformations present in the solid 
state. X-ray diffraction data determined at low temperature 
(– 73°C) yielded a structure practically identical to that at 
room temperature. 
 The observation of both possible chair conformations 
in crystals of Gpn derivatives suggests that the two forms 
may not be significantly different in energy, resulting in 
an appreciable population of both structures in solution. 
Crystallization may be kinetically controlled by poorly-
understood nucleation events, with the added possibility 
that packing forces can determine the conformation selected 
in crystals. 
Crystal packing 
In view of the large number of crystal structures present d, 
we describe only a selected set of four examples which 
illustrate specific features of molecular packing in crystals 
(Figures 4a, b). On going from Gpn 1 to the hydrochloride 
hemihydrate 2, there is an inversion of the cyclohexane ring. 
Inspection of the packing diagram reveals that an intra-
molecular hydrogen bond is formed between one of the 
amino hydrogens and the carboxyl group of the carboxylic 
acid. Molecules in the crystal are linked together by bridging 
chloride ions and a single water molcule. The water 
mol cule occupies a special position (Figure 4 a). The 
packing arrangement in Gpn lactam 3, consists of a 
closed dimeric motif in which the cis amide group forms 
a pair of hydrogen bonds. In the packing of is amides, as 
in dioxopiperazines, two forms of packing rra ements 
have been observed, namely the closed dimeric motif and the 
more common displaced arrangement, where a continuous  
network of hydrogen bonds stabilizes the crystal29. The 
packing diagrams for one example each of a protected 
Gpn derivative with the aminomethyl group in the axial 
(Piv-Gpn-OH 6) and equatorial (Boc-Gpn-OH 4) orienta-
ti ns are illustrated in Figure 4 b. The two molecules differ 
by only the single oxygen atom of the urethane (Boc) 
group, which is absent in the corresponding ivaloyl deri-
vative. Both molecules adopt similar conformations ta-
bilized by a single intramolecular hydrogen bond  
between the NH and CO group of Gpn. Interestingly, in 
both cases a single intermolecular OH×××O hydrogen bond 
between the carbonyl group of the Piv or Boc moieties 
and the Gpn carboxylic acid O–H group stabilizes the 
crystal. It appears that the orientation of the substituents 
on the cyclohexane ring is not a function of crystal pack-
ing forces; rather the observed conformations in crystals 
may be selected by nucleating factors. 
Solution equilibria: NMR studies 
Figure 5 shows the temperature dependence of the methy-
lene proton resonances of the aminomethyl (2.7–3.1 d ) 
and carboxymethyl (2.3–2.5 d) groups in Gpn. The  
Table 2. Conformational parameters in the gabapentin residuea 
       
       
 
Compounds 
  
f (deg) 
 
q1 (deg) 
 
q2 (deg) 
 
y (deg) 
Aminomethyl  
group 
              
Gabapentin 1  – 59.7  51.1  Axial 
Gabapentin HClb 2  – 66.4 – 83.2 – 124.5 Equatorial 
Gabapentin lactam 3   21.6 – 21.9  Axial 
Boc-Gpn-OHb 4   119.6 57.4  40.0   79.7 Equatorial 
Ac-Gpn-OHb 5  – 101.3 59.0  75.9 – 79.4 Equatorial 
Piv-Gpn-OHb 6    99.8 45.3  53.1  100.9 Axial 
Tosyl-Gpn-OH 7  
 (four molecules) 
A  144.6 66.7  63.8 – 86.8 (– 5.1)c Axial 
 B  146.9 69.0  65.3 – 88.4 (– 4.0)c Axial 
 C – 124.7 59.9  61.7 – 171.1 Axial 
 D – 124.1 59.6  61.0 – 169.4 Axial 
Boc-Gpn-OSu 8   102.4 61.1  68.2 – 94.6 Equatorial 
Boc-Gpn-NHMed 9b   125.5 68.7  52.8 – 118.5 e 
       
       
aAll derivatives are achiral and crystallize in centrosymmetric space groups. One sign of the dihedral 
angle is chosen arbitrarily. The dihedral angles are defined as f = C¢–N–Cg–Cb, q1 = N–Cg–Cb–Ca, 
q2 = Cg–Cb–Ca–C¢ and y = Cb–Ca–C¢–O (ref. 30). 
bIntramolecular hydrogen bonds are observed in these structures: 2 (N1×××O1 = 2.76 Å, H×××O1 
= 2.05 Å, Ð N1–H×××O1 = 136.7°), 4 (N1×××O1 = 3.08 Å, H×××O1 = 2.50 Å, Ð N1–H×××O1  = 133.3°), 
5 (O0×××O2 = 2.54 Å, O0×××H = 1.55 Å, Ð O0×××H–O2 = 173.3°), 6 (N1×××O1 = 2.97 Å, H×××O1 = 2.37 Å, 
Ð N1–H×××O1 = 129.0°). 
cThe terminal carboxylic acid group has a disorder with an occupancy ratio of 0.7: 0.3 and the 
corresponding y values are given in parentheses. 
dValues are listed only for the structure obtained at low temperature. 
eThe two conformations, amino ethyl group axial and equatorial, coexist with an occupancy ratio 
of 0.7 : 0.3. 
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Figure 4. View of packing in crystals of (a) Gpn hydrochloride 2 and gabapentin lactam 3; and (b) Boc-Gpn-OH 4 and Piv-Gpn-OH 6. 
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resonances appear as a sharp singlet at ~ 30°C, suggest-
ing rapid interconversion between the two possible chair 
conformations of the cyclohexane ring. Upon cooling to  
– 80°C, two distinct sets of resonances can be observed 
for each of the methylene groups. The more intense pair 
of resonances corresponds to the conformation with the 
aminomethyl group in an equatorial position. The un-
ambiguous assignment of stereochemistry was made 
possible by the analysis of the spectra of a constrained 
Gpn analogue, which is incapable of conformational inter-
conversion (unpublished). Interestingly, the conformation 
observed for Gpn in crystals (reported above and in ref. 
12) corresponds to the major conformation observed in 
solution, i.e. aminomethyl group is equatorial. The results 
of an identical set of NMR experiments carried out on the 
fully protected derivative Boc-Gpn-NHMe are also shown 
in Figure 5. Once again, at – 71°C two sets of resonances 
corresponding to two possible chair conformations of the 
cyclohexane ring are observed. In this case, the two chair 
conformations are more equally popu ated. Interestingly, 
in crystals, as noted earlier, both conformations are obser-
ved with an occupancy of 0.7 : 0.3; the form with the amino-
methyl group axial being predominant. Table 3 summarizes 
the population ratios for the two cyclohexane ring confor-
mations determined for Gpn and its eight derivatives. The 
free energy difference between the two forms is slightly 
larger in the case of Gpn 1 a d Gpn hydrochloride 2, com-
pared to the other derivatives. Indeed, protection of the 
amino and carboxyl groups appears to result in diminish-
ing the free-energy difference between the two forms. 
Almost equal populations are observed in Boc-Gpn-
NHMe 9. The crystallographic investigation on Gpn and 
several of its derivatives suggests that two possible chair 
conformations of the 1,1-disubstituted cyclohexane ring 
can be observed in the solid state. Figure 6 shows a super-
position of nine independent Gpn units determined in this 
study. Three structures, Gpn hydrochloride, Gpn lactam 
and Boc-Gpn-NHMe are excluded. Two conformational 
families are clearly identifiable. Evidently, the nature of 
the conformation captured in crystals may be determined 
by crystal packing forces and also by kinetic nucleation 
events. It is noteworthy that both forms are present in the 
crystals of Boc-Gpn-NHMe 9, resulting in static disorder 
Table 3. Conformational distribution and NMR parameters for Gpn and derivatives 
     
     
d (ppm)c 
 
 
 
Compound 
 
Pax : Peq 
(CH2NH)a 
 
DG  
(kcal mol–1) 
 
Tcb  
(°C) CgHax CgHeq CaHax CaHeq                 
Gpn 1 0.27 : 0.73 0.38 – 44, – 44 3.05 2.76 2.51 2.27 
Gpn HCl 2 0.29 : 0.71 0.33 – 46, – 46 3.22 2.93 2.54 2.32 
Gpn lactam 3 0.48 : 0.52 0.02 – 39, – 41 3.25 3.09 2.26 2.12 
Boc-Gpn-OH 4 0.38 : 0.62 0.19 – 50, – 50 3.21 3.00 2.34 2.08 
Ac-Gpn-OH 5 0.47 : 0.53 0.05 – 47, – 47 3.42 3.17 2.37 2.13 
Piv-Gpn-OH 6 0.40 : 0.60 0.15 – 49, – 49 3.34 3.13 2.35 2.13 
Tosyl-Gpn-OH 7 0.39 : 0.61 0.17 – 40, – 50 3.81 3.63 2.86 2.62 
Boc-Gpn-OSu 8 0.41 : 0.59 0.14 – 51, – 47 3.23 3.03 2.70 2.40 
Boc-Gpn-NHMe 9 0.49 : 0.51 0.01 – 45, – 45 3.15 2.92 2.17 1.95 
                
aRatio of the forms with the aminomethyl group axial or equatorial determined under conditions of 
slow exchange at – 70 to - 86°C in methanol (CD3O ). Peak areas were determin d manually. 
bCoalescence temperature estimated from the two sets of resnances (–CH2NH– and –CH2–COOH). 
For Tosyl-Gpn-OH the frequency difference between the two forms is uch larger for the –CH2–COOH 
group compared to the –CH2–NH2 group, resulting in significantly different coalescence temperatures 
for the two sets of resonances. 
cChemical shifts of the methylene protons of the –CH2–NH– (CgH2) and –CH2–COOH (CaH2) groups 
determined under conditions of slow exchange at – 70 to -86°C. 
 
 
 
Figure 5. Partial 400 MHz 1H NMR spectra in CD3OD at various 
temperatures. Only the CH2–N and CH2–CO proton resonances are 
shown. a, Gpn; b, Boc-Gpn-NHMe. 
 
a 
b 
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involving the cyclohexane ring. NMR studies confirm 
that relatively small free energy differences separate the 
two possible chair conformations, resulting in an appreci-
able population of both forms in solution. In view of the 
widespread of use of Gpn in diverse clinical applications, 
it may be of some interest to further probe the conforma-
tional requirements of the pharmacological receptors for 
this molecule. 
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Figure 6. Superposition of nine Gpn moieties determined in crystal 
structures. Seven atoms, N, Cg, Cb, Ca, C¢ Cb1 and Cb2, are used for the 
superposition. (RMSD = 1.0358 Å). 
 
